Migraine medications and psilocybin.
21 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Also searched as migraine medication · triptan · triptans · CGRP · migraine
01 What the evidence covers
Best evidence available per medication| 21 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to Z- Acetaminophen–aspirin–caffeine · Excedrin Extra Strength, Excedrin MigraineEvidence: No psilocybin data
Minor aches and pains (headache, colds, arthritis, muscular aches, toothache, menstrual cramps); Migraine
Its caffeine may add to psilocybin's brief rise in heart rate. Acetaminophen and aspirin are not studied with psilocybin.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- AlmotriptanEvidence: No psilocybin data
Migraine attacks (acute treatment, adults); Migraine headache pain in adolescents 12 to 17 (acute treatment)
It may add to psilocybin's serotonin activity and brief blood pressure rise. Also, its label reports rare significant blood pressure elevation.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine prevention
Not studied with psilocybin; its label reports new or worsened high blood pressure, which may add to psilocybin's brief blood pressure rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment); Cluster headache episodes (acute treatment, injection)
It narrows blood vessels and has rarely raised blood pressure, which may add to psilocybin's rise. Also, uncontrolled high blood pressure is a label contraindication.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
It may add to psilocybin's serotonin effects and blood pressure rise (not studied with psilocybin). Also, it narrows blood vessels and rarely spikes blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine prevention (adults)
Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine prevention
Not studied with psilocybin. Also, its label reports high blood pressure, most often within a week of a dose, and constipation.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine and other vascular headaches (to stop or prevent attacks); Cluster headache (histaminic cephalalgia)
It may add to psilocybin's blood pressure rise, since it strongly narrows blood vessels; it also acts on serotonin receptors.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine prevention (adults); Episodic migraine prevention (age 6 to 17, weight 45 kg or more)
Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
- FrovatriptanEvidence: No psilocybin data
Migraine attacks (acute treatment)
It may add to psilocybin's serotonin effects and blood pressure rise (not studied with psilocybin); a dose from the day before may linger.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine prevention (adults); Episodic cluster headache (adults)
Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure, which psilocybin also briefly raises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment, with or without aura)
Its label reports hallucinations and euphoria, which may add to psilocybin's effects, and it causes sleepiness and dizziness.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
Not studied with psilocybin; both parts can raise blood pressure and one acts on serotonin, so added effects are possible.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks, with or without aura (acute treatment in adults)
It narrows blood vessels and acts on serotonin, so it may add to psilocybin's effects and blood pressure rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment); Prevention of episodic migraine
Not studied with psilocybin; no linking mechanism is described; its label reports raised blood pressure, which may add to psilocybin's rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment, adults and children 6 and older)
It may add to psilocybin's serotonin effects and blood pressure rise (not studied). Also, its label reports rare significant blood pressure elevation.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment); Cluster headache attacks (acute treatment, injection)
Its serotonin activity may add to psilocybin's effects and blood pressure rise. Also, its label reports rare significant blood pressure rises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Acute treatment of migraine with or without aura (adults and children 12 and older)
Sumatriptan's serotonin activity may add to psilocybin's effects and brief blood pressure rise. Also, its label reports rare significant blood pressure rises.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
Not studied with psilocybin; no linking mechanism is described; its label reports raised blood pressure, which may add to psilocybin's brief rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
Not studied with psilocybin; no linking mechanism is described. Its label reports new or worse high blood pressure; psilocybin also briefly raises blood pressure.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Migraine attacks (acute treatment)
Its serotonin activity may add to psilocybin's effects and blood pressure rise.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 20 | Raises blood pressure or heart rate |
| 12 | Serotonergic |
| 2 | Liver injury |
| 2 | Lowers seizure threshold or carries seizure risk |
| 1 | Psychiatric reactions |
| 1 | Sedating or CNS depressant |
| 1 | Withdrawal or rebound if stopped abruptly |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRelated classes
- Pain relievers3 shared
Records reviewed 2026-10-03 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z